This grant, offered by the National Cancer Institute (NCI), is for advancing the science of scaling-up and sustaining lung cancer screening (LCS) among populations at high risk. Its purpose is to identify the most effective implementation strategies for delivering LCS across various clinical care settings and diverse high-risk groups. This initiative aims to maximize the impact of evidence-based interventions. Utilizing a UG3/UH3 phased cooperative agreement, the initial UG3 phase supports preparatory activities crucial for the scale-up and sustainment trial. Subsequently, the UH3 phase will fund the execution of the full scale-up and sustainment trial, ensuring long-term impact in cancer prevention.
Opportunity ID: 356618
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-25-009 |
| Funding Opportunity Title: | Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.399 — Cancer Control |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 02, 2024 |
| Last Updated Date: | Oct 02, 2024 |
| Original Closing Date for Applications: | Dec 06, 2024 |
| Current Closing Date for Applications: | Dec 06, 2024 |
| Archive Date: | Jan 11, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Private institutions of higher education City or township governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments For profit organizations other than small businesses Special district governments Public and State controlled institutions of higher education State governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to advance the science of scale-up and sustainment of lung cancer screening (LCS) for populations at high risk for lung cancer. This NOFO will support studies that will identify the most effective implementation strategies for scaling-up and sustaining the delivery of LCS across a range of clinical care settings and diverse populations at high risk for lung cancer. This NOFO will use the UG3/UH3 phased cooperative agreement mechanism. The UG3 phase will support preparatory activities for the scale-up and sustainment trial. The UH3 phase will support the scale-up and sustainment trial. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-009.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 356618 Full Announcement-RFA-CA-25-009 -> RFA-CA-25-009-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00288043 | Nov 06, 2024 | Jan 24, 2025 | View |
Package 1
Mandatory forms
356618 RR_SF424_5_0-5.0.pdf
356618 PHS398_CoverPageSupplement_5_0-5.0.pdf
356618 RR_OtherProjectInfo_1_4-1.4.pdf
356618 PerformanceSite_4_0-4.0.pdf
356618 RR_KeyPersonExpanded_4_0-4.0.pdf
356618 RR_Budget10_3_0-3.0.pdf
356618 PHS398_ResearchPlan_5_0-5.0.pdf
356618 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356618 RR_SubawardBudget10_30_3_0-3.0.pdf
356618 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
